325 related articles for article (PubMed ID: 12185408)
1. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
Berrendero F; Maldonado R
Psychopharmacology (Berl); 2002 Aug; 163(1):111-7. PubMed ID: 12185408
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Balerio GN; Aso E; Maldonado R
Psychopharmacology (Berl); 2005 Sep; 181(2):260-9. PubMed ID: 15778877
[TBL] [Abstract][Full Text] [Related]
4. Involvement of opioid system in cognitive deficits induced by ∆⁹-tetrahydrocannabinol in rats.
Egashira N; Manome N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
Psychopharmacology (Berl); 2012 Feb; 219(4):1111-8. PubMed ID: 21858449
[TBL] [Abstract][Full Text] [Related]
5. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
Smith PB; Welch SP; Martin BR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952
[TBL] [Abstract][Full Text] [Related]
6. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide.
Agmo A; Belzung C
Neuropharmacology; 1998; 37(2):223-32. PubMed ID: 9680247
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
Reche I; Fuentes JA; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(1):11-6. PubMed ID: 9007506
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptors and acetaminophen (paracetamol).
Raffa RB; Walker EA; Sterious SN
Eur J Pharmacol; 2004 Oct; 503(1-3):209-10. PubMed ID: 15496316
[TBL] [Abstract][Full Text] [Related]
10. A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice.
Reche I; Fuentes JA; Ruiz-Gayo M
Eur J Pharmacol; 1996 Apr; 301(1-3):75-81. PubMed ID: 8773449
[TBL] [Abstract][Full Text] [Related]
11. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
12. Anxiety does not affect the antinociceptive effect of Delta 9-THC in mice: participation of cannabinoid and opioid receptors.
Takahashi RN; Ramos GA; Assini FL
Pharmacol Biochem Behav; 2003 Jul; 75(4):763-8. PubMed ID: 12957217
[TBL] [Abstract][Full Text] [Related]
13. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Welch SP
J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
[TBL] [Abstract][Full Text] [Related]
14. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
Kamei J; Saitoh A; Kasuya Y
Neurosci Lett; 1995 Aug; 196(3):169-72. PubMed ID: 7501275
[TBL] [Abstract][Full Text] [Related]
15. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
16. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897
[TBL] [Abstract][Full Text] [Related]
17. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
Gao L; Yu LC
Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920
[TBL] [Abstract][Full Text] [Related]
18. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
19. Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.
Rodgers RJ; Augar R; Berryman N; Hansom CJ; O'Mahony ML; Palmer RM; Stevens A; Tallett AJ
Psychopharmacology (Berl); 2006 Aug; 187(3):345-55. PubMed ID: 16802164
[TBL] [Abstract][Full Text] [Related]
20. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
